Evidence map›Paper›PMID 33202710›Full record

ArticleBiology2020

Deficiency of Splicing Factor 1 (SF1) Reduces Intestinal Polyp Incidence in

Jyotsna D Godavarthi, Shahrazad Polk, Lisa Nunez, Amruthesh Shivachar, Nancy L Glenn Griesinger, Angabin Matin

Open access · goldAbstract read
In one paragraph

Article in Biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jyotsna D GodavarthiDepartment of Pharmaceutical Sciences, Texas Southern University, Houston, TX 77004, USA.ORCID 0000-0002-4548-9917
Shahrazad PolkDepartment of Pharmaceutical Sciences, Texas Southern University, Houston, TX 77004, USA.
Lisa NunezDepartment of Pharmaceutical Sciences, Texas Southern University, Houston, TX 77004, USA.
Amruthesh ShivacharDepartment of Pharmaceutical Sciences, Texas Southern University, Houston, TX 77004, USA.
Nancy L Glenn GriesingerDepartment of Mathematics, Texas Southern University, Houston, TX 77004, USA.
Angabin MatinDepartment of Pharmaceutical Sciences, Texas Southern University, Houston, TX 77004, USA.ORCID 0000-0002-7592-3438
Texas Southern University · US

Funding

Targeted Nano-drug-delivery-systems of Frist-in-class Drugs for CRPC: PK/PD Evaluation and Combination TherapyU54MD007605 · NIMHD · TEXAS SOUTHERN UNIVERSITY · PI Dong Liang, Huan Xie · 2020 to 2026
$22.0M
NIH HHS NCI R21CA186033NIH HHS NIMHD 5G12MD007605NIMHD NIH HHS U54 MD007605
6 · The paper itself

Abstract

backgroundSplicing factor 1 (SF1) is a conserved alternative splicing factor expressed in many different mammalian cell types. The genetically modified

methodsWe utilized mice genetically deficient for expression of SF1 to assess how SF1 levels affect intestinal tumorigenesis. We crossed

resultsOur results showed that

conclusionsOur results suggest that lower SF1 levels likely inhibit the rate of initiation of polyp development due to

Indexed as

APC (adenomatous polyposis coli)polypsplicing factor 1 (SF1)

Identifiers

PMID33202710
PMCPMC7697247
OpenAlexW3098420013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.